Obesity News

Weight loss presented as a positive opportunity by physicians was associated with greater uptake of treatment and weight loss, a study published in Annals of Internal Medicine found.

WASHINGTON —Pediatric obesity and guidelines on how to manage it were the focus of several symposiums at the AAP National Conference & Exhibition.

The FDA approved the injectable GIP/GLP-1 dual incretin-based agonist tirzepatide for chronic weight management among adults with obesity, according to a press release.

Researchers observed a dose-dependent relationship between increasing maternal BMI and higher postpartum infection risk after different delivery modes, according to findings published in The Journal of Maternal-Fetal & Neonatal Medicine.

DENVER — Integrating lifestyle coaching in a primary care model was feasible and significantly improved several dietary measures and health outcomes, according to data presented at the Lifestyle Medicine Conference.

Adults with type 2 diabetes and obesity achieved greater weight loss with time-restricted eating at 6 months than with calorie restriction or continuing usual eating habits, according to study data.

DENVER — Lifestyle medicine is a central component of obesity treatment, including for adults who receive anti-obesity medications or undergo bariatric surgery, according to three speakers at the Lifestyle Medicine Conference.

Women living in low- and middle-income countries have a higher prevalence of obesity and other cardiometabolic disorders than men, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Obesity is one of the most common chronic preventable comorbidities affecting adults and children in the United States.

DENVER — Following a plant-based eating plan can help people with obesity lose weight without the use of medications or bariatric surgery, according to a speaker at the Lifestyle Medicine Conference.